Company announcements

Announcement type

All

Price-sensitive

Stock code or name

leave blank for all companies

Headline

leave blank for all announcements

Sector

Market Cap ($m)

Announcement date

View top

announcements

Order By

Ascending

Descending

Reset Filters

Search Results

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Reinstatement to Official Quotation	6 Aug 2008 10:34AM	$0.090	$12.480	risen by 13,766.67%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Neuren raises a minimum of $3 million	6 Aug 2008 10:34AM	$0.084	$12.480	risen by 14,757.14%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Suspension from Official Quotation	31 Jul 2008 10:02AM	n/a	$12.480	n/a
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Trading Halt	29 Jul 2008 10:08AM	n/a	$12.480	n/a
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Glypromate and NNZ 2566 in Top 10 Neuroscience Projects	21 Jul 2008 8:59AM	$0.130	$12.480	risen by 9,500%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Neuren to get early results from Glypromate trial	30 Jun 2008 8:32AM	$0.110	$12.480	risen by 11,245.45%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Response to ASX Query re: Appendix 4C	26 May 2008 5:52PM	$0.105	$12.480	risen by 11,785.71%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Positive interim safety analysis for Glypromate	15 May 2008 9:09AM	$0.110	$12.480	risen by 11,245.45%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Appendix 4C - quarterly	30 Apr 2008 3:38PM	$0.110	$12.480	risen by 11,245.45%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Quarterly Update to Shareholders April 2008	29 Apr 2008 3:28PM	$0.105	$12.480	risen by 11,785.71%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Appendix 4E Preliminary Final Report	29 Feb 2008 2:27PM	$0.120	$12.480	risen by 10,300%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Rights issue raises $7.1m and notes convert	11 Feb 2008 2:08PM	$0.130	$12.480	risen by 9,500%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Neuren Appendix 4C December 2007	31 Jan 2008 3:54PM	$0.150	$12.480	risen by 8,220%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	US Department of Defense Approves NNZ2566 Funding	21 Jan 2008 1:15PM	$0.170	$12.480	risen by 7,241.18%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Glypromate trial recruits 100th patient	17 Jan 2008 9:32AM	$0.145	$12.480	risen by 8,506.90%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Rights Issue NZ Investment Statement and Prospectus	19 Dec 2007 5:19PM	$0.160	$12.480	risen by 7,700%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Neuren announces non-renounceable rights issue	19 Dec 2007 10:26AM	$0.200	$12.480	risen by 6,140%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Trading Halt	17 Dec 2007 10:03AM	n/a	$12.480	n/a
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	NNZ-2566 successful Phase 1b trial results	7 Nov 2007 9:30AM	$0.340	$12.480	risen by 3,570.59%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Appendix 4C - quarterly	31 Oct 2007 2:55PM	$0.250	$12.480	risen by 4,892%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Neuren completes acquisition of Hamilton Pharmaceuticals	16 Oct 2007 12:28PM	$0.265	$12.480	risen by 4,609.43%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Neuren launches Australian Phase 3 Trial Sites	26 Sep 2007 9:18AM	$0.280	$12.480	risen by 4,357.14%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Neuren completes moderate TBI safety trial	20 Sep 2007 9:57AM	$0.280	$12.480	risen by 4,357.14%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	NZ arm of Phase 3 trial commences	7 Sep 2007 4:09PM	$0.290	$12.480	risen by 4,203.45%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$1,579	Half Yearly Report and Accounts	31 Aug 2007 2:48PM	$0.290	$12.480	risen by 4,203.45%

726 - 750 of 800 results

Page 30 of 32

+ Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.